1. Home
  2. PLRX vs AMBC Comparison

PLRX vs AMBC Comparison

Compare PLRX & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • AMBC
  • Stock Information
  • Founded
  • PLRX 2015
  • AMBC 1991
  • Country
  • PLRX United States
  • AMBC United States
  • Employees
  • PLRX N/A
  • AMBC N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • AMBC Property-Casualty Insurers
  • Sector
  • PLRX Health Care
  • AMBC Finance
  • Exchange
  • PLRX Nasdaq
  • AMBC Nasdaq
  • Market Cap
  • PLRX 680.3M
  • AMBC 543.0M
  • IPO Year
  • PLRX 2020
  • AMBC 1991
  • Fundamental
  • Price
  • PLRX $11.37
  • AMBC $11.51
  • Analyst Decision
  • PLRX Strong Buy
  • AMBC Strong Buy
  • Analyst Count
  • PLRX 7
  • AMBC 2
  • Target Price
  • PLRX $40.50
  • AMBC $17.00
  • AVG Volume (30 Days)
  • PLRX 485.5K
  • AMBC 431.2K
  • Earning Date
  • PLRX 02-26-2025
  • AMBC 02-25-2025
  • Dividend Yield
  • PLRX N/A
  • AMBC N/A
  • EPS Growth
  • PLRX N/A
  • AMBC N/A
  • EPS
  • PLRX N/A
  • AMBC N/A
  • Revenue
  • PLRX N/A
  • AMBC $398,000,000.00
  • Revenue This Year
  • PLRX N/A
  • AMBC N/A
  • Revenue Next Year
  • PLRX N/A
  • AMBC N/A
  • P/E Ratio
  • PLRX N/A
  • AMBC N/A
  • Revenue Growth
  • PLRX N/A
  • AMBC 22.46
  • 52 Week Low
  • PLRX $10.22
  • AMBC $10.12
  • 52 Week High
  • PLRX $18.00
  • AMBC $18.45
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 44.60
  • AMBC 45.24
  • Support Level
  • PLRX $10.35
  • AMBC $11.35
  • Resistance Level
  • PLRX $11.07
  • AMBC $11.72
  • Average True Range (ATR)
  • PLRX 0.61
  • AMBC 0.31
  • MACD
  • PLRX 0.06
  • AMBC 0.05
  • Stochastic Oscillator
  • PLRX 43.50
  • AMBC 59.15

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About AMBC Ambac Financial Group Inc.

Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.

Share on Social Networks: